Our aim was to investigate in pediatric NAFLD the mechanisms underlying the effects of DHA administration on histo-pathological aspects, GPR120 expression, hepatic progenitor cell activation and macrophage pool. The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatotic liver disease.